In the News | Charles River
   
 
 
   
   

How to Ensure the Best Chance of Success for Your Therapeutic Proteins Program
Life Science Leader – November 5, 2009

The exciting field of biotechnology-derived therapeutic proteins, or biologics, has the potential to yield important medical breakthroughs in just about every branch of medicine. However, due to the size and complexity of these unique therapeutic proteins, the process for safely overcoming regulatory hurdles and bringing a biologic to market is vastly different from the processes for any other type of pharmaceutical. This problem is compounded due to the fact that the drug development process for individual biologics also differ greatly from each other and that no clear regulatory guidance exists for each type of biologics...Read the full article.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

(Country Code)+800.3195.3430
askcharlesriver@crl.com

view all

Events

view all
juin 14-juin 14 - Hørsholm, Denmark - Biotech Outsourcing Strategies (chemistry, manufa...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA, US

Charles River Laboratories, Inc.